Conversation on Twitter :
@FierceMedDev: Industry groups urge Congress to delay device tax. Story | Follow @FierceMedDev
@MarkHFierce: Research at Columbia proposes the use of a prenatal genetic test as standard of care--it's much more comprehensive. Item | Follow @MarkHFierce
@DamianFierce: In case you missed it, we rounded up some industry reaction to the final medical device tax regs. Story | Follow @DamianFierce
> Anika Therapeutics ($ANIK) loses again: The FDA upheld its earlier non-approvable decision for the company's Monovisc PMA. Monovisc is a hyaluronic viscosupplement injection designed to treat small synovial joint pain, and it's already approved in Europe. Release
> Suture Express, a specialty supplier of sutures and other surgical supplies, filed a $200 million antitrust lawsuit against Cardinal Health and Owens & Minor, alleging that the wholesale distributors of medical and surgical supplies unfairly prevent their customers from using specialty suppliers. Release
> Volcano ($VOLC) is looking to raise $400 million in convertible senior notes due in 2017. Item
> Bunnell is recalling its Life Pulse High-Frequency Ventilator Patient Circuits, warning that they can overheat and send smoke into the humidifier cartridge. More
> Thermedx in Ohio hopes to raise $5 million in the coming year to support expansion centered around its fluid management surgical device. Story
> Derma Sciences ($DSCI), a medical device and pharmaceutical company focused on wound care, is pursuing a public offering to raise money, in part, for clinical development programs. Release
> Johnson & Johnson's ($JNJ) ex-head of medical devices and diagnostics is now chairman of the board at EOS imaging, and will help the orthopedic medical imaging company pursue international expansion. Release
Biotech News
@FierceBiotech: Eli Lilly touts antibody that reverses symptom of Alzheimer's. News | Follow @FierceBiotech
@JohnCFierce: Biotech upstart Moderna nails down $40M for bold RNA idea. Article | Follow @JohnCFierce
@RyanMFierce: FDA is on track to increase new drug approvals again. But is it enough? Story (sub. req.) | Follow @RyanMFierce
> FDA matches most new drug approvals in years in 2012; Is it enough? Report
> Against tough odds, Lundbeck touts high-stakes R&D end game. Story
> Biotech upstart Moderna nails down $40M for bold RNA idea. Article
Pharma News
@FiercePharma: Teva investors want new CEO Jeremy Levin to say he has their back in next week's analyst presentation. News | Follow @FiercePharma
> EU's top court backs antitrust fight in ruling against AstraZeneca. Report
> Another pharma free speech case hits U.S. appeals court. Story
Vaccines News
@AlisonBFierce: FhCMB lands up to $9.9M from NIH for anthrax vaccine research. More | Follow @AlisonBFierce
> Flu season arrives a month early. Item
> DARPA tackles the DNA vaccine. Article
> Protein Sciences expands flu vaccine operations to Pfizer site. More
> Altravax lands $3.45M from NIH for HIV vaccine research. News
> Sanofi Pasteur nabs Menactra expansion in Canada. Story
Pharma Manufacturing News
> Sun setting on Sunovion Canadian API plant. Article
> Cargo theft law puts target on organized crime. News
> Lilly taps Strides, Agila for cancer med manufacturing. Story
> FDA registration deadline looms for generic drugmakers. Report